Living With Gout? Consider Joining a Clinical Trial.
Join the RUBY Study of a possible treatment for adults with gout who still have flare-ups despite taking allopurinol. The RUBY Study will test how effective and safe a study drug called dotinurad may be in treating gout, compared to allopurinol.
You may be able to join the RUBY Study if you:
Are 18 to 75 years old
Have been diagnosed with gout for at least 1 year
Have had at least 2 gout flares in the last 12 months before joining the study
Have been taking the same dose of allopurinol for at least 3 months
If you qualify, you may receive at no cost:
Either dotinurad or study-supplied allopurinol
Monitoring by the study team throughout the study
Reimbursement for reasonable study-related expenses (travel and meals)